Nu-Med Plus, Inc. (NUMD)

OTCMKTS · Delayed Price · Currency is USD
0.0102
-0.0050 (-32.89%)
At close: May 15, 2026
Market Cap852.19K -85.0%
Revenue (ttm)n/a
Net Income-52.13K
EPS-0.00
Shares Out 83.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume700
Open0.0102
Previous Close0.0152
Day's Range0.0102 - 0.0102
52-Week Range0.0097 - 0.0600
Beta-2.26
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About Nu-Med Plus

Nu-Med Plus, Inc., a medical device company, engages in the design, innovation, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers. It is also involved in the development of a mobile rechargeable device to deliver nitric oxide gas; and a nitric oxide system that can be used for research applications, as well as a mobile/portable rechargeable ... [Read more]

Sector Healthcare
Founded 2011
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol NUMD
Full Company Profile

Financial Performance

Financial Statements